ECUADOR Trends and Developments Contributed by: Byron Robayo, Mario Cedeño and Lorena Sandoval Campaña, Estudio Spingarn & Marks S.A.
tax authority. Compliance with this requirement is not bureaucracy – it is the difference between a fiscally efficient technology transfer and one that destroys part of the value it was designed to generate. Trade secrets: the invisible asset The trade secret is probably the most widely used IP asset in Ecuador and, simultaneously, the least sys- tematically protected. Every company operating in a competitive market has trade secrets, even if it does not identify them as such: product formulas, client lists, production methods, pricing strategies and pro- prietary algorithms. All information that is not public, generates competitive advantage and is subject to reasonable confidentiality measures qualifies, under Articles 303 to 320 of the Ingenios Code and Andean Community Decision 486, as a legally protected trade secret. The protection of a trade secret is not obtained through registration – there is no trade secret registry – but through an internal confidentiality architecture. When that architecture does not exist or is poorly constructed, information flows without control, and the company loses its competitive position before the violation is even apparent. The minimum elements of that architecture include: • non-disclosure agreements with employees, con- tractors and commercial partners; • post-employment confidentiality clauses and, where valid, non-compete provisions; • access controls for sensitive information and docu- mented data handling protocols; and • joint venture and co-development agreements with clear IP ownership and assignment clauses. Enforcement: building protection into the contract When a trade secret violation occurs – a departing employee who takes the client portfolio, a commer- cial partner who replicates the product formula – the honest assessment is that Ecuador’s judicial system does not offer the certainty or speed these disputes require. The absence of specialised IP courts, limited judicial familiarity with valuing intangible assets and the procedural timelines of ordinary litigation make the judicial route, in most cases, a long path to an uncertain outcome.
Arbitration has emerged as the mechanism of choice for resolving sophisticated IP disputes in Ecuador. The structural advantages are clear: • the confidentiality of proceedings protects the information at stake from further exposure; • arbitrators can be selected for their technical or sectoral expertise; and • awards are internationally enforceable under the New York Convention. Arbitral tribunals have begun to recognise and sanc- tion trade secret violations with a sophistication that ordinary courts have yet to achieve, including recog- nising the undue competitive advantage obtained as a measure of damages and granting urgent interim measures through emergency arbitrator mechanisms. Effective IP protection in Ecuador is built into the con- tract architecture before the problem arises – not liti- gated after the damage is done. Pharmaceutical test data: a miscalibrated protection Article 509 of the Ingenios Code grants a five-year exclusivity period – ten years for biological entities – to the first applicant to obtain a sanitary registration in Ecuador for a pharmaceutical product containing a “new chemical entity”. The economic rationale is sound: those who invest in generating original clinical evidence deserve a period during which competitors cannot rely on that evidence to obtain their own reg- istration. The problem lies in how the health authority has interpreted the concept that activates this protection. In practice, a territorial reading of novelty has been adopted: a molecule is “new” if it is new in Ecuador, regardless of its history in the international market. Under this interpretation, a compound that has been on the global market for 15 years, whose product pat- ent has expired and whose clinical data has circulated in scientific literature for years receives test data pro- tection in Ecuador the moment its holder first applies for sanitary registration in the country. The result is paradoxical and harmful: the system grants five years of exclusivity – blocking generic entry
101 CHAMBERS.COM
Powered by FlippingBook